= LhARA pre-CDR Meeting 26th Nov 2019 = == Meeting details == 14:00 Room 532, Blackett Lab. Zoom details: Join Zoom Meeting https://ukri.zoom.us/j/865262978 Phone one-tap: United Kingdom: +442034815237!,,865262978# or +442039663809!,,865262978# Join by Telephone For higher quality, dial a number based on your current location. United Kingdom: +44 203 481 5237\\ +44 203 966 3809\\ +44 131 460 1196\\ +44 203 051 2874 Meeting ID: 865 262 978 Join from an H.323/SIP room system H.323: 162.255.37.11 (US West) 162.255.36.11 (US East) 221.122.88.195 (China) 115.114.131.7 (India) 213.19.144.110 (EMEA) 103.122.166.55 (Australia) 209.9.211.110 (Hong Kong) 64.211.144.160 (Brazil) 69.174.57.160 (Canada) 207.226.132.110 (Japan) Meeting ID: 865 262 978 International numbers https://ukri.zoom.us/u/ap9aBI2Eh SIP: 865262978@zoomcrc.com \\ Skype for Business (Lync) https://ukri.zoom.us/skype/865262978 \\ Skype on a SurfaceHub SIP: 865262978@lync.zoom.us https://ukri.zoom.us/skype/865262978 == Agenda == * Action items from last meeting. * CW to arrange meeting with JPo, ZN and OE. * AK to add solenoid details (from the GPT input file) to the parameter list document. * AK to note the instrumentation requirements for the definition of the baseline. * AK to update previous parameter table and circulate Overleaf link. * OE to circulate what was done for safety case for the laser in 027. * [wiki:/Research/DesignStudy/PreCDR#Floorplan Floor plan updates] * [https://ccap.hep.ph.ic.ac.uk/trac/raw-attachment/wiki/Research/DesignStudy/PreCDR/2019-11-05-WBS.pdf Work breakdown structure] * [https://ccap.hep.ph.ic.ac.uk/trac/raw-attachment/wiki/Research/DesignStudy/PreCDR/2019-11-15-Interfaces.pdf Interfaces document] * [raw-attachment:LhARA_parameter_list.pdf​ Parameter table] * System updates and outstanding issues for the 29th Nov deadline. * Laser driven proton and ion source. * Proton and ion capture. * Stage 1 beam transport: Beam transport and delivery to the in vitro end station. * Stage 2 beam transport: Post-acceleration and beam delivery to the in vivo end station. * Biological end stations. * Infrastructure and Integration. * Project plan for the delivery of LhARA. * Safety. * End-to-end simulation. * Instrumentation. * A.O.B. * Plenary meeting talks. == Notes == Present: Apologies: == Action Items ==